Voloridge Investment Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,984
| Closed | -$672K | – | 1175 |
|
|
2024
Q3 | $672K | Sell |
27,984
-20,161
| -42% | -$484K | ﹤0.01% | 1061 |
|
|
2024
Q2 | $959K | Sell |
48,145
-79,221
| -62% | -$1.58M | ﹤0.01% | 1057 |
|
|
2024
Q1 | $2.54M | Buy |
127,366
+72,311
| +131% | +$1.44M | 0.01% | 807 |
|
|
2023
Q4 | $1.23M | Sell |
55,055
-55,304
| -50% | -$1.24M | ﹤0.01% | 920 |
|
|
2023
Q3 | $2.23M | Buy |
110,359
+92,948
| +534% | +$1.88M | 0.01% | 893 |
|
|
2023
Q2 | $445K | Buy |
+17,411
| New | +$445K | ﹤0.01% | 1247 |
|
|
2023
Q1 | – | Sell |
-69,140
| Closed | -$1.87M | – | 1358 |
|
|
2022
Q4 | $1.87M | Sell |
69,140
-41,306
| -37% | -$1.12M | 0.01% | 981 |
|
|
2022
Q3 | $2.41M | Sell |
110,446
-18,076
| -14% | -$394K | 0.01% | 932 |
|
|
2022
Q2 | $3.51M | Buy |
128,522
+239
| +0.2% | +$6.54K | 0.02% | 803 |
|
|
2022
Q1 | $4.3M | Buy |
128,283
+20,568
| +19% | +$689K | 0.02% | 687 |
|
|
2021
Q4 | $3.73M | Sell |
107,715
-18,552
| -15% | -$643K | 0.02% | 820 |
|
|
2021
Q3 | $3.94M | Buy |
126,267
+64,459
| +104% | +$2.01M | 0.03% | 774 |
|
|
2021
Q2 | $2.25M | Buy |
+61,808
| New | +$2.25M | 0.02% | 953 |
|
|
2020
Q3 | – | Sell |
-14,062
| Closed | -$413K | – | 1241 |
|
|
2020
Q2 | $413K | Buy |
+14,062
| New | +$413K | ﹤0.01% | 1069 |
|
|
2020
Q1 | – | Sell |
-6,980
| Closed | -$235K | – | 1087 |
|
|
2019
Q4 | $235K | Buy |
+6,980
| New | +$235K | ﹤0.01% | 973 |
|
|
2019
Q2 | – | Sell |
-20,105
| Closed | -$858K | – | 755 |
|
|
2019
Q1 | $858K | Buy |
+20,105
| New | +$858K | 0.03% | 525 |
|